S1P/S1PRs-TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis.

Yeliva (opaganib) - RedHill

http://www.ncbi.nlm.nih.gov/pubmed/39581852

Chan Zhu; Changming Wang; Fang Wang; Guang Yu; Jiahui Ren; Mingxin Qi; Pei Liu; Weimeng Feng; Xinyu Zhang; Xue Li; Yan Yang; Yin Wang; Yuan Zhou; Yuxiang Ma; Zongxiang Tang

Nov 25, 2024